Following the key announcement from the company on Wednesday, it is quite likely that Enzolytics Inc (OTCMKTS:ENZC) is going to come onto the radars of investors this morning. The company was in the news yesterday after it made an announcement with regard to the preliminary toxicology report in relation to its ITV-1 anti-HIV therapeutic.
Enzolytics Announces Preliminary Results of GLP Toxicology Study for its anti-HIV Therapeutic ITV-1 and Production of ITV-1 for Initiation of Registration in Africa
The report confirmed that the therapy was not only non-toxic but also demonstrated that it was safe to administer. It was a major new development for Enzolytics considering the fact that the establishment of the result was actually essential for getting permission under the provisions of the European Medicines Agency.
It is also essential for the product to be accepted for administration to patients in Africa. The protocols and tests that had been conducted for the same were on a GLP-Compliant Intramuscular Dose and that had then been followed up with a recovery period of 4 weeks. Now that the preliminary study has been completed, Enzolytics believes it would soon enter the markets in Kenya, DR Congo, Botswana and Rwanda. Investors could do well to keep an eye on further developments and watch for the price action in the stock.